CERTIFIED & ACCREDITED • CAP Accredited • CLIA Certified • NY State Licensed • 21 CFR Part 11 Compliant • ISO 13485 • CERTIFIED & ACCREDITED • CAP Accredited • CLIA Certified • NY State Licensed • 21 CFR Part 11 Compliant • ISO 13485 •CERTIFIED & ACCREDITED • CAP Accredited • CLIA Certified • NY State Licensed • 21 CFR Part 11 Compliant • ISO 13485 • CERTIFIED & ACCREDITED • CAP Accredited • CLIA Certified • NY State Licensed • 21 CFR Part 11 Compliant • ISO 13485 •

Advanced BioPharma Laboratory Services for Translational and Clinical Success

End-to-end biomarker discovery, assay development, clinical testing and bioinformatics powered by high-throughput platforms and regulatory excellence.

A True Partner Across Your Drug Development Lifecycle

Our BioPharma service platform delivers end-to-end solutions for translational research, biomarker discovery, assay development, clinical testing, and bioinformatic data analysis. We support IHC, Multiplex Immunofluorescence (mIF), qPCR, and NGS — enabling comprehensive molecular and cellular insights across all therapeutic areas.

Whether you are a small biotech or a large pharmaceutical company, we partner with clients to provide scientific, technical, and operational support throughout the entire project lifecycle — from discovery through clinical implementation.

Emerging Biotech & Startups

We act as an extension of your team;

  • Enabling rapid execution without internal infrastructure investment.
  • Flexible engagement models,
  • Fast onboarding
  • Consultative scientific support allows emerging companies to accelerate timelines and de-risk development from early biomarker discovery through clinical validation

Large Pharmaceutical Companies

Enterprise-grade laboratory services designed to integrate;

  • Seamlessly into global drug development programs.
  • Standardized workflows
  • Full regulatory compliance (CAP, CLIA, NY)
  • High-throughput capabilities support large,
  • Multi-site clinical trials with consistency and audit-ready
    deliverables.

Move Your Drug Development and Clinical Programs Forward, Faster

Biomarker & Assay Development

We provide comprehensive biomarker discovery services including target identification, validation, and translation into clinically actionable assays. Our team supports full lifecycle assay development including feasibility, optimization, analytical validation, and clinical validation across multiple platforms.

Focus on scientific expertise:

  • Biomarker discovery

  • Target validation
  • Assay design and optimization
  • Analytical and clinical validation
  • Translational research support

Clinical Testing

All clinical testing is performed in laboratories operating under rigorous quality management systems and accredited by CAP, CLIA, and New York State. We ensure compliance with regulatory requirements and industry best practices for clinical diagnostics, including documentation, validation, and reporting standards.

Clinical and regulatory focus:

  • CAP, CLIA, NY-accredited testing
  • Clinical trial support
  • Sample logistics and accessioning
  • Reporting and compliance
  • Audit readiness and documentation

Quality & Regulatory

Our processes incorporate robust quality control measures at every stage:

  • Sample accessioning and chain-of-custody tracking
  • Internal and external QC controls for each assay
  • Data integrity verification and audit trails

  • Standardized SOPs aligned with regulatory guidelines

  • Continuous monitoring and improvement under a formal QMS

Quality systems and compliance:

  • Quality Management System (QMS)

  • SOPs and validation frameworks

  • QC checkpoints and controls

  • Data integrity and traceability
  • Regulatory compliance language

Comprehensive BioPharma Services

Each service is validated, CAP/CLIA-compliant, and designed to produce reproducible, audit-ready data. All platforms feed into a unified bioinformatics layer for seamless cross-study analysis.

Immunohistochemistry (IHC) Services

Precision Tissue-Based Biomarker Analysis for Translational and Clinical Research

Our Immunohistochemistry (IHC) services deliver robust, reproducible protein expression data across preclinical and clinical samples, supporting biomarker discovery, validation, and regulatory-grade studies.

Core Capabilities
  • Chromogenic IHC assay development and optimization
  • Automated staining (high-throughput platforms)
  • FFPE and fresh frozen tissue processing
  • Antibody validation and titration workflows
  • Whole slide imaging and digital pathology integration
Applications in Biopharma
  • Companion diagnostic development
  • Clinical trial biomarker stratification
  • Tumor microenvironment characterization
  • Target engagement and pharmacodynamic readouts
Advanced Technical Features
  • Standardized antigen retrieval and detection chemistries
  • Batch-controlled staining for cross-study consistency
  • AI-enabled image analysis (quantification, scoring, segmentation)
  • Pathologist-reviewed scoring (H-score, % positivity, intensity)
Quality & Regulatory Compliance
  • CAP/CLIA-aligned workflows
  • SOP-driven assay validation and documentation
  • Full chain-of-custody and audit-ready data

Multiplex Immunofluorescence (mIF) Services

High-Plex Spatial Biology for Immuno-Oncology and Translational Research

Our multiplex immunofluorescence platform enables simultaneous detection of multiple biomarkers within a single tissue section, unlocking spatial insights critical for modern drug development.

Core Capabilities
  • 5–8+ plex panel design and validation
  • TSA-based amplification systems
  • Spectral imaging and signal unmixing
  • Automated staining and slide scanning
Applications in Biopharma
  • Immuno-oncology biomarker discovery
  • Mechanism-of-action studies
  • Patient stratification and response prediction
  • Spatial profiling in clinical trials
Advanced Technical Features
  • Co-localization and spatial proximity analysis
  • Cell phenotyping (immune and tumor subsets)
  • Batch harmonization across large clinical studies
  • Batch harmonization across large clinical studies
Quality & Scale
  • Reproducible panel validation pipelines
  • High-throughput slide processing
  • Cross-cohort comparability for multi-site trials

Next-Generation Sequencing (NGS) Services

Comprehensive Genomic Profiling for Precision Medicine

Our NGS services deliver end-to-end sequencing solutions, from sample preparation to advanced bioinformatics, enabling deep genomic insights.

Sequencing Capabilities
  • Targeted Panels: Oncology panels, hotspot mutations, custom gene panels
  • Whole Exome Sequencing (WES): Coding region analysis
  • Whole Genome Sequencing (WGS): Structural variants, CNVs, full genome
Applications in Drug Development
  • Biomarker discovery and validation
  • Patient stratification and precision medicine
  • Resistance mechanism identification
  • Clinical trial genomic endpoints
Technical Workflow
  • Library preparation and QC
  • High-throughput sequencing platforms
  • Coverage optimization and uniformity control
  • Variant calling, annotation, and filtering
Quality & Compliance
  • CLIA/CAP-aligned sequencing workflows
  • Data traceability and audit readiness
  • High-throughput processing for large trials

PCR / qPCR Services

High-Sensitivity Molecular Quantification for Clinical and Translational Studies

We provide highly sensitive and precise PCR/qPCR testing for gene expression, mutation detection, and clinical biomarker analysis.

Core Capabilities
  • Quantitative real-time PCR (qPCR)
  • Gene expression profiling
  • Mutation and SNP detection
  • Copy number variation analysis
  • Custom assay design
Clinical & Biopharma Applications
  • Clinical trial biomarker endpoints
  • Minimal residual disease (MRD) detection
  • Viral load quantification
  • Translational research validation
Advanced Technical Excellence
  • Validated primer/probe design workflows
  • Standard curve-based quantification
  • Multiplex qPCR assays
  • High-throughput automation
Regulatory & QC
  • CLIA, CAP, and NY-compliant testing
  • Internal controls and replicate validation
  • Rapid turnaround for clinical studies

Multi-Omics Analysis Services

Integrated Multi-Omics for Holistic Biological Insights

We combine genomics, transcriptomics, proteomics, and spatial data to deliver comprehensive insights into disease biology and therapeutic response.

Core Capabilities
  • Cross-platform data integration (NGS, qPCR, protein, mIF)
  • Pathway and systems biology analysis
  • Biomarker discovery across data layers
  • Data harmonization across studies
Biopharma Applications
  • Precision medicine strategies
  • Translational research programs
  • Complex disease modeling
Advanced Analytics

CiberMed’s iSort™ Fractions: quantifies the composition of 22 immune cell types, plus fibroblasts, endothelial, and epithelial cells in Tissue mode.CiberMed’s iSort™ HiRes: infers cell type–specific gene expression profiles, enabling biomarker discovery and transcriptional profiling across conditions.

  • Network and pathway modeling
  • Predictive biomarker identification
  • Mechanism-of-action insights

Bioinformatics & Data Analysis Services

End-to-End Bioinformatics for Scalable, Regulatory-Ready Insights

Our bioinformatics platform supports all data modalities, delivering secure, scalable, and audit-ready analysis pipelines.

Core Capabilities
  • NGS pipelines (alignment, variant calling, annotation)
  • RNA-seq, microRNA, and expression analysis
  • Image analysis for IHC and mIF
  • Statistical modeling and biostatistics
Advanced Capabilities
  • Machine learning for biomarker discovery
  • Multi-omics integration pipelines
  • Predictive modeling and outcome correlation
  • Custom pipeline development
Data Integrity & Compliance
  • 21 CFR Part 11–aligned workflows
  • Full audit trails and reproducibility
  • Secure data environments
Biopharma Value
  • Faster decision-making with integrated analytics
  • Scalable support for global clinical trials
  • Regulatory-ready reporting and documentation

Laboratory Infrastructure Built for High-Throughput Execution

Our laboratories are designed for high-volume sample processing with advanced automation and optimized workflows ensuring rapid turnaround without compromising quality — supporting large-scale clinical trials worldwide.

We deliver comprehensive, customizable reports with actionable insights. Data outputs are tailored to client needs, including raw data, processed results, and integrated analyses. All reporting adheres to regulatory and client-specific requirements.

  • IHC and mIF for spatial biology and tissue-based biomarker analysis
  • qPCR and PCR for gene expression and mutation detection
  • NGS for genomic, transcriptomic, and microRNA profiling
  • High-volume automation and workflow optimization
  • Data analysis, bioinformatics, and biostatistics
  • Custom assay development and multi-platform integration

Start Your Project Consultation

Let’s discuss your science.

Whether you’re scoping a new biomarker program, designing a clinical trial assay strategy, or looking for a long-term laboratory partner, our team is ready to help.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Location*
How Did You Hear About Us?